Logo

Meridian Bioscience

New Products Posted to GenomeWeb: Natera, Sema4, Meridian Bioscience, More

Meridian Bioscience Fiscal Q3 Revenues Drop 25 Percent

The company has seen reduced demand for reagents related to COVID-19 testing compared to record highs in 2020.

Meridian Bioscience Fiscal Q3 Preliminary Revenues Drop 25 Percent

The diagnostics segment was negatively impacted by supply chain issues with reagents causing back orders toward the end of the quarter.

Meridian Bioscience Resubmits Revogene SARS-CoV-2 Test to FDA for EUA

The company withdrew its application in February to conduct additional studies after receiving guidance from the FDA.

New Products Posted to GenomeWeb: Centogene, Meridian Bioscience, Oxford Nanopore, More

May 7, 2021

Meridian Bioscience Fiscal Q2 Revenues Up 49 Percent

Apr 6, 2021

NIH RADx Program Awards $29.3M to Increase SARS-CoV-2 Testing Capacity

Apr 1, 2021

GenomeWeb Index Falls Again in March, Led by 29 Percent Decline in Adaptive Biotech Stock

Feb 23, 2021

Meridian Withdraws Emergency Use Authorization Application to FDA for Coronavirus MDx Test

Feb 16, 2021

Meridian Shares Drop as Much as 15 Percent on FDA Questions About SARS-CoV-2 Test

Feb 5, 2021

Meridian Bioscience Fiscal Q1 Revenues Rise 96 Percent

Feb 3, 2021

Meridian Bioscience Receives $5.5M From NIH to Expand SARS-CoV-2 Test Production

Jan 7, 2021

Meridian Bioscience Preliminary Fiscal 2021 Q1 Revenues Up 94 Percent

Dec 16, 2020

Meridian Bioscience Receives $1M NIH Grant for SARS-CoV-2 Test Launch

Nov 13, 2020

Meridian Bioscience Q4 Revenues Climb 26 Percent, Beat Street Estimate

Oct 26, 2020

Moving From Reagents Supplier to Test Developer, Meridian Bio Expands Role During COVID-19 Pandemic
Premium

Sep 1, 2020

Meridian Bioscience Leads Decliners in August as GenomeWeb Index Falls 4 Percent

Aug 27, 2020

As Abbott Stock Rises on EUA for Antigen Test, Competitors' Shares Take a Hit

Aug 7, 2020

Meridian Bioscience Fiscal Q3 Revenues Soar 75 Percent on COVID-19-Related Life Sciences Growth

Jul 2, 2020

Surge in Stocks of SARS-CoV-2 Dx Developers Pushes GenomeWeb Index Up 15 Percent in H1 2020

Jul 1, 2020

Invitae Stock Skyrockets in June on ArcherDx Acquisition, Leading GenomeWeb Index

Jun 1, 2020

Fluidigm Leads May GenomeWeb Index on Early Detection SARS-Cov-2 Blood Test Collaboration Details

May 22, 2020

People in the News: Tony Serafini-Lamanna, Martin Chavez, Sun Kim, Oved Amitay, More

May 11, 2020

William Blair Upgrades Meridian Bioscience to Outperform

May 8, 2020

Meridian Bioscience Posts 14 Percent Revenue Increase in Fiscal Q2, Raises FY2020 Guidance

Breaking News
The Scan

US Booster Eligibility Decision

The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions.

Arizona Bill Before Judge

The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction.

Additional Genes

Wales is rolling out new genetic testing service for cancer patients, according to BBC News.

Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification

In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.